Feasibility of dual-task gait to estimate Alzheimer's related cognitive decline in Down syndrome

Kathryn L. Van Pelt, Lisa Koehl, Allison Caban-Holt, Amelia Anderson-Mooney, Elizabeth Head, Frederick A. Schmitt

Research output: Contribution to journalArticlepeer-review

1 Scopus citations


Introduction: The striatum and frontal lobes have been shown to have early Alzheimer's disease (AD) neuropathology and are critical for motor and cognitive function. We hypothesized gait would be associated with early-stage dementia in Down syndrome (DS), a cohort at risk for AD. Methods: Twenty-eight participants with DS were enrolled in the study. Participants walked at their self-selected pace and while completing a dual task (counting, obstacle, or counting+obstacle). Results: All participants were able to complete the self-paced condition and 78.57–96.42% completed the dual-task conditions. There was a trend for greater dual-task effects on gait velocity based on dementia diagnosis. Gait velocity had stronger associations with clinical dementia assessments than age or diagnosis. Discussion: A dual-task gait paradigm is feasible to conduct with adults with DS and is associated with age and cognitive impairment. Dual-task gait may serve as an indicator of early stage dementia in DS.

Original languageEnglish
Article numbere12092
JournalAlzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring
Issue number1
StatePublished - 2020

Bibliographical note

Funding Information:
This work was supported by the National Institutes of Health (R01‐HD064993‐09S1, T32 AG057461).

Publisher Copyright:
© 2020 The Authors. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring published by Wiley Periodicals LLC on behalf of Alzheimer's Association


  • aging
  • dementia
  • dual-task effect
  • gait speed
  • trisomy21

ASJC Scopus subject areas

  • Clinical Neurology
  • Psychiatry and Mental health


Dive into the research topics of 'Feasibility of dual-task gait to estimate Alzheimer's related cognitive decline in Down syndrome'. Together they form a unique fingerprint.

Cite this